Your browser doesn't support javascript.
Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19.
Rhoads, Daniel D; Cherian, Sree S; Roman, Katharine; Stempak, Lisa M; Schmotzer, Christine L; Sadri, Navid.
  • Rhoads DD; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA ddr26@case.edu.
  • Cherian SS; Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
  • Roman K; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
  • Stempak LM; Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
  • Schmotzer CL; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
  • Sadri N; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
J Clin Microbiol ; 58(8)2020 Jul 23.
Article in English | MEDLINE | ID: covidwho-1343943

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Nasopharynx / Coronavirus Infections / Clinical Laboratory Techniques / Molecular Diagnostic Techniques / Betacoronavirus / Nasal Mucosa Type of study: Diagnostic study / Prognostic study Limits: Humans Country/Region as subject: North America Language: English Year: 2020 Document Type: Article Affiliation country: JCM.00760-20

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Nasopharynx / Coronavirus Infections / Clinical Laboratory Techniques / Molecular Diagnostic Techniques / Betacoronavirus / Nasal Mucosa Type of study: Diagnostic study / Prognostic study Limits: Humans Country/Region as subject: North America Language: English Year: 2020 Document Type: Article Affiliation country: JCM.00760-20